ARIAD Pharma (ARIA) Posts Q3 Loss of 21c, Misses Views by 3c
ARIA Hot Sheet
EPS Growth %: 0.0%Financial Fact:
Net income (loss): -55.89M
Today's EPS Names:
TARO, BRLI, TLB, More
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) reports Q3 loss of $0.21, versus the analyst estimate of ($0.18). Revenue for the quarter was $2.16 billion, which compares to the estimate of $2.59 billion.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Mentor Graphics Corp (MENT) Beats Q1 EPS View by 5c; Lifts FY13 Outlook
- Pandora (P) Blows Up Expectations as Listener Hours Rip; Guides FY13 Ahead of Views
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
